Jim Cramer weighs in on the U.S.-China trade war, how the trade war affects Salesforce, and Amgen's deal to acquire the rights to Celgene's Otezla.

Sign up for ActionAlertsPLUS.com today for exclusive insight into Jim Cramer’s charitable portfolio: https://buff.ly/2khDJhL